These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15221283)

  • 21. [Efficacy of once-per-cycle administration pegylated recombinant human granulocyte colony-stimulating factor in chemotherapy-induced neutropenia in a phase I trial].
    Yang S; Shi YK; Liu P; Han XH; He XH; Cai YM; Chen ZM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Jun; 28(3):339-44. PubMed ID: 16900629
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders.
    Yamane A; Mori T; Suzuki S; Mihara A; Yamazaki R; Aisa Y; Nakazato T; Shimizu T; Ikeda Y; Okamoto S
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):100-6. PubMed ID: 17222758
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources.
    Walker CM; van Burik JA; De For TE; Weisdorf DJ
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1106-15. PubMed ID: 17697973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pilot phase II study of alternate day ganciclovir and foscarnet in preventing cytomegalovirus (CMV) infections in at-risk pediatric and adolescent allogeneic stem cell transplant recipients.
    Shereck EB; Cooney E; van de Ven C; Della-Lotta P; Cairo MS
    Pediatr Blood Cancer; 2007 Sep; 49(3):306-12. PubMed ID: 16972242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Varicella-zoster virus disease is more frequent after cord blood than after bone marrow transplantation.
    Vandenbosch K; Ovetchkine P; Champagne MA; Haddad E; Alexandrov L; Duval M
    Biol Blood Marrow Transplant; 2008 Aug; 14(8):867-71. PubMed ID: 18640569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cord blood transplantation for acute lymphoblastic leukemia in children: analysis at a single institution].
    Kobayashi R; Sato T; Nakajima M; Kaneda M; Iguchi A; Yoshida M
    Rinsho Ketsueki; 2008 Dec; 49(12):1593-8. PubMed ID: 19110519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for cytomegalovirus, hepatitis B and C virus reactivation after bone marrow transplantation.
    Zekri AR; Mohamed WS; Samra MA; Sherif GM; El-Shehaby AM; El-Sayed MH
    Transpl Immunol; 2004 Dec; 13(4):305-11. PubMed ID: 15589744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation.
    Einsele H; Ehninger G; Hebart H; Wittkowski KM; Schuler U; Jahn G; Mackes P; Herter M; Klingebiel T; Löffler J; Wagner S; Müller CA
    Blood; 1995 Oct; 86(7):2815-20. PubMed ID: 7670117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-grade cytomegalovirus antigenemia after hematopoietic stem cell transplantation.
    Asano-Mori Y; Oshima K; Sakata-Yanagimoto M; Nakagawa M; Kandabashi K; Izutsu K; Hangaishi A; Motokura T; Chiba S; Kurokawa M; Hirai H; Kanda Y
    Bone Marrow Transplant; 2005 Nov; 36(9):813-9. PubMed ID: 16151428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surveillance of nosocomial sepsis and pneumonia in patients with a bone marrow or peripheral blood stem cell transplant: a multicenter project.
    Dettenkofer M; Wenzler-Röttele S; Babikir R; Bertz H; Ebner W; Meyer E; Rüden H; Gastmeier P; Daschner FD;
    Clin Infect Dis; 2005 Apr; 40(7):926-31. PubMed ID: 15824981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lenograstim for the treatment of neutropenia in patients receiving ganciclovir for cytomegalovirus infection: a randomised, placebo-controlled trial in AIDS patients.
    Dubreuil-Lemaire ML; Gori A; Vittecoq D; Panelatti G; Tharaux F; Palisses R; Gharakhanian S; Rozenbaum W;
    Eur J Haematol; 2000 Nov; 65(5):337-43. PubMed ID: 11092465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Once daily ganciclovir as initial pre-emptive therapy delayed until threshold CMV load > or =10000 copies/ml: a safe and effective strategy for allogeneic stem cell transplant patients.
    Verkruyse LA; Storch GA; Devine SM; Dipersio JF; Vij R
    Bone Marrow Transplant; 2006 Jan; 37(1):51-6. PubMed ID: 16284613
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preemptive therapy with intravenous ganciclovir for the prevention of cytomegalovirus disease in lung transplant recipients.
    Monforte V; Román A; Gavaldà J; Bravo C; Gispert P; Pahissa A; Morell F
    Transplant Proc; 2005 Nov; 37(9):4039-42. PubMed ID: 16386621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of postengraftment infectious morbidity and mortality after allogeneic partially T cell-depleted peripheral blood progenitor cell transplantation versus T cell-depleted bone marrow transplantation.
    Broers AE; van der Holt B; Haze S; Braakman E; Gratama JW; Löwenberg B; Cornelissen JJ
    Exp Hematol; 2005 Aug; 33(8):912-9. PubMed ID: 16038784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ganciclovir for the treatment of cytomegalovirus gastroenteritis in bone marrow transplant patients. A randomized, placebo-controlled trial.
    Reed EC; Wolford JL; Kopecky KJ; Lilleby KE; Dandliker PS; Todaro JL; McDonald GB; Meyers JD
    Ann Intern Med; 1990 Apr; 112(7):505-10. PubMed ID: 2156476
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacteriological infections during the first hundred days of allogenic bone marrow transplantation--experience from Oman.
    Ghosh K; Shenoy AK; Al-Mahrooqi Z
    J Assoc Physicians India; 2002 Jul; 50():910-2. PubMed ID: 12126346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of ganciclovir-induced neutropenia with recombinant human GM-CSF.
    Sulecki M; Rosenfeld CS; Przepiorka D; Bloom EJ; Buhles W; Shadduck RK
    Am J Med; 1991 Mar; 90(3):401-2. PubMed ID: 1848397
    [No Abstract]   [Full Text] [Related]  

  • 38. Regimen-related mucosal injury of the gut increased the incidence of CMV disease after allogeneic bone marrow transplantation.
    Shigematsu A; Yasumoto A; Yamamoto S; Sugita J; Kondo T; Onozawa M; Kahata K; Endo T; Ota S; Sato N; Takahata M; Okada K; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
    Biol Blood Marrow Transplant; 2009 Jun; 15(6):679-85. PubMed ID: 19450752
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Significance of qualitative PCR detection method for preemptive therapy of cytomegalovirus infection in patients after allogeneic hematopoietic stem cell transplantation -- single-centre experience.
    Skapova D; Racil Z; Dvorakova D; Minarikova D; Mayer J
    Neoplasma; 2005; 52(2):137-42. PubMed ID: 15800712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myeloablative unrelated cord blood transplantation for acute leukemia patients between 50 and 55 years of age: single institutional retrospective comparison with patients younger than 50 years of age.
    Konuma T; Takahashi S; Ooi J; Tomonari A; Tsukada N; Kato S; Sato A; Monma F; Kasahara S; Nagamura-Inoue T; Uchimaru K; Iseki T; Tojo A; Yamaguchi T; Asano S
    Ann Hematol; 2009 Jun; 88(6):581-8. PubMed ID: 19030858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.